{"id":113070,"date":"2023-06-15T21:58:55","date_gmt":"2023-06-15T21:58:55","guid":{"rendered":"http:\/\/www.brandon.ddtest.info\/multisite-test\/using-health-technology-assessment-to-inform-insurance-reimbursement-of-high-technology-medicines-in-china-an-example-of-cancer-immunotherapy-the-bmj\/"},"modified":"2023-06-15T21:58:55","modified_gmt":"2023-06-15T21:58:55","slug":"using-health-technology-assessment-to-inform-insurance-reimbursement-of-high-technology-medicines-in-china-an-example-of-cancer-immunotherapy-the-bmj","status":"publish","type":"post","link":"http:\/\/www.brandon.ddtest.info\/multisite-test\/using-health-technology-assessment-to-inform-insurance-reimbursement-of-high-technology-medicines-in-china-an-example-of-cancer-immunotherapy-the-bmj\/","title":{"rendered":"Using health technology assessment to inform insurance reimbursement of high technology medicines in China: an example of cancer immunotherapy – The BMJ"},"content":{"rendered":"

\n<\/p>\n

    \n
  1. Using health technology assessment to inform insurance reimbursement of high technology medicines in China: an example of cancer immunotherapy<\/a>  The BMJ<\/font><\/li>\n
  2. Use of health technology assessment in drug reimbursement decisions in China<\/a>  The BMJ<\/font><\/li>\n
  3. Use of real world data to improve drug coverage decisions in China<\/a>  The BMJ<\/font><\/li>\n
  4. Health technology assessment to inform decision making in China: progress, challenges, and sustainability<\/a>  The BMJ<\/font><\/li>\n
  5. How health technology reassessment can support disinvestment in China’s national drug reimbursement list<\/a>  The BMJ<\/font><\/li>\n
  6. View Full Coverage on Google News<\/a><\/strong><\/li>\n<\/ol>\n\n
    Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

    Using health technology assessment to inform insurance reimbursement of high technology medicines in China: an example of cancer immunotherapy  The BMJ Use of health technology assessment in drug reimbursement decisions in China  The BMJ Use of real world data to improve drug coverage decisions in China  The BMJ Health technology assessment to inform decision making in China: progress, …<\/p>\n","protected":false},"author":1,"featured_media":113071,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[161],"tags":[],"_links":{"self":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/113070"}],"collection":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/comments?post=113070"}],"version-history":[{"count":0,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/posts\/113070\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media\/113071"}],"wp:attachment":[{"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/media?parent=113070"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/categories?post=113070"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.brandon.ddtest.info\/multisite-test\/wp-json\/wp\/v2\/tags?post=113070"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}